Advancing OSD: Continuous Production Considerations and Dose-Level Authentication

Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1564898&tp_key=5fb16734d9

Event Overview:

In this exclusive Drug Digest video interview, Felicity Thomas and Feliza Mirasol, Pharmaceutical Technology editors, interview experts in solid dosage development and manufacturing. Alex Trombley, OSD Process Specialist/Business Development Manager of Syntegon runs through the benefits of continuous OSD production and some key considerations for containment and operator safety, while an expert [Speaker TBD] from Colorcon highlights the importance of authentication at the dose level.

Interviews Featuring:

• Alex Trombley, OSD Process Specialist/Business Development Manager, Syntegon
• Expert from Colorcon
  

Key Learning Objectives:

• Key benefits of continuous OSD production
• State of industry adoption of continuous OSD
• Containment technologies in OSD production
• Key authentication factors at the dose-level for OSD products
  

Speakers:

Alex Trombley
OSD Process
Specialist/Business
Development Manager
Syntegon

Alex Trombley is Syntegon’s Business Development Manager where he is focused on technical support, customer trials, and market development for Huttlin products in North. Alex is experienced in early phase formulation development, process identification, scale-up, and technology transfer and has worked extensively with continuous manufacturing, high shear granulation, fluid bed granulation, tableting, and coating.

Time and Date:

Thursday, September 28, 2022 at 11am ET | 10am CT | 8am PT

Sponsors:

• Adare Pharmaceuticals
• Ascendia Pharma
• Coating Place
• Festo
• JRS Pharma Family
• Veltek Associates, Inc.

Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1564898&tp_key=5fb16734d9